| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |